The bird flu questions that scientists desperately want answered

STAT asked scientists who have long worked on influenza or in veterinary medicine for their pressing questions about the bird flu outbreak.

June 5, 2024 Check out STAT+

Sponsored By

Illustration: Christine Kao/STAT; Photos: Getty, Adobe, AP, CDC and NIAID These are the bird flu questions that influenza and animal scientists desperately want answered Many of the experts we asked said what's known about how H5N1 is spreading among cows cannot be the whole story. By Helen Branswell STAT+ | As Washington mulls new AI rules, startup leaders want a seat at the table Startup leaders are eager to be heard in D.C. as federal regulators try to put in place guardrails to ensure AI doesn't harm patients. By Mohana Ravindranath Finland to offer bird flu vaccine to select groups of people, a possible global first Mia Kontio, a health security official at the Finnish Institute for Health and Welfare, told STAT the country was waiting for 20,000 doses to arrive. By Andrew Joseph Illustration: STAT; Source: Eli Lilly/AP STAT+ | Eli Lilly's obesity drug Zepbound improved liver scarring in mid-stage MASH study Lilly's biggest competitor in the space, Novo Nordisk, is currently testing its obesity drug Wegovy in MASH in a Phase 3 trial. By Elaine Chen Opinion: Listen: Among pregnant people, active treatment for addiction shouldn't trigger a call to child protective services This week's "First Opinion Podcast" looks at the hazards that pregnant people in active treatment for opioid addiction face. By Patrick Skerrett STAT+ | Appeals court overturns Sutter Health's victory in $400 million antitrust case An appeals court overturned Sutter's win in a case alleging the health system drove up health care costs across California. By Tara Bannow Christopher Furlong/Getty Images Opinion: 100,000 models show that not much was learned about stopping the Covid-19 pandemic Did government responses in 181 countries in 2020 and 2021 affect outcomes in the Covid-19 pandemic? 100,000 models show it's hard to say. By Eran Bendavid and Chirag Patel STAT+ | Gilead to pay $40 million to settle claims it delayed newer HIV treatment to boost profits The agreement caps a dispute that cast a spotlight on a strategy Gilead allegedly used to maximize revenues but at the expense of patients. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser